Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in LYEL — Lyell Immunopharma, Inc.

CIK 1214717 BOSTON, MA
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$4,364,435
+$1,014,817 QoQ
Shares Held
310,636
+86.0% QoQ
Ownership
1.27%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 87 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. LYEL ranks #255 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in LYEL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,364,435 310,636
2026-03-31 $3,349,618 166,980
2025-12-31 $5,017,046 162,997
2025-09-30 $2,115,373 130,257
2025-06-30 $912,906 103,270
2025-03-31 $2,366,735 4,399,139
2024-12-31 $2,647,848 4,137,264
2024-09-30 $5,547,545 4,019,961
2024-06-30 $5,817,476 4,012,053
2024-03-31 $8,957,956 4,017,021
2023-12-31 $7,638,459 3,937,350
2023-09-30 $5,375,030 3,656,483
2023-06-30 $10,735,133 3,375,828
2023-03-31 $7,524,706 3,188,435
2022-12-31 $10,590,457 3,052,005
2022-09-30 $21,628,264 2,950,650
2022-06-30 $12,232,087 1,876,087
2022-03-31 $7,343,876 1,454,233
2021-12-31 $4,324,539 558,726
2021-09-30 $7,871,898 531,885
2021-06-30 $2,832,580 174,420